Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.

Source:http://linkedlifedata.com/resource/pubmed/id/20973922

Download in:

View as

General Info

PMID
20973922